At sacrifice time, tumor volume was >2-fold higher in the control-ASO treated group (3640.5 mm3 +/− 470,538 mm3) compared to the Menin-ASO treated group (1514 mm3 +/− 163,443 mm3; ***P ≤ 0.001). Here, MEN1 is linked to neoplasm.